Keyword: Active Pharmaceutical Ingredients (APIs)

News

IMCD Expands Pharmaceuticals Technical Centre and Wins Laura Marshall Award

26.11.2024 -

IMCD Group, a global distribution partner and formulator of specialty chemicals and ingredients, recently announced the expansion of its Pharmaceuticals Technical Centre...

News

Cambrex Announces New Peptide Synthesis Manufacturing Technology

26.09.2024 -

Cambrex announced that Snapdragon Chemistry, a Cambrex company, has developed a new liquid-phase peptide synthesis (LPPS) technology utilizing active pharmaceutical...

News

Olon Acquires Huvepharma Italia

04.09.2024 -

Olon continues its growth path and increases its total production capacity following the acquisition of Huvepharma Italia and its site in Garessio, Cuneo, in the...

News

Pfizer Opens Expanded API Manufacturing Site in Singapore

25.07.2024 -

Pfizer has commissioned its expanded, highly automated active pharmaceutical ingredient (API) manufacturing facility at the Tuas Biomedical Park in Singapore.

News

Siegfried to Acquire Early-Phase CDMO in US

13.06.2024 -

Siegfried, a global Contract Development and Manufacturing Organization (CDMO) for the pharmaceutical industry headquartered in Zofingen, Switzerland, has signed binding...

News

Sterling Expands HPAPI Capabilities at US Facility

04.06.2024 -

UK-headquartered contract development and manufacturing organization (CDMO) Sterling Pharma Solutions has invested $3 million at its US facility in Germantown, WI, to...

News

Lilly Increases Investment in Indiana Site to $9 Billion

27.05.2024 -

Eli Lilly plans to invest another $5.3 billion in its US manufacturing site Lebanon, Indiana, increasing the company's total investment in this site $9 billion. The...

News

CEFIC Joins EU’s Critical Medicines Alliance to Strengthen API Supply

02.05.2024 -

The European Chemical Industry Council (CEFIC), through its subgroup European Fine Chemicals Group (EFCG), joined the Critical Medicines Alliance, an initiative of the...